{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:37:20Z","timestamp":1790728640490,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jbc.2025.108520","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T02:23:16Z","timestamp":1745029396000},"page":"108520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimization of the PROTAC linker region of the proteasome substrate receptor hRpn13 rationalized by structural modeling with molecular dynamics"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9591-7334","authenticated-orcid":false,"given":"Xiuxiu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4558-2812","authenticated-orcid":false,"given":"Venkata R.","family":"Sabbasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2079-6387","authenticated-orcid":false,"given":"Bakar","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-7202","authenticated-orcid":false,"given":"Rolf E.","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie J.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.108520_bib1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.tibs.2022.06.006","article-title":"Proteasome substrate receptors and their therapeutic potential","volume":"47","author":"Osei-Amponsa","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jbc.2025.108520_bib2","article-title":"A high affinity hRpn2-derived peptide that displaces human Rpn13 from proteasome in 293T cells","volume":"10","author":"Lu","year":"2015","journal-title":"PLoS one"},{"key":"10.1016\/j.jbc.2025.108520_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15540","article-title":"Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets","volume":"8","author":"Lu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.108520_bib4","doi-asserted-by":"crossref","first-page":"9493","DOI":"10.1074\/jbc.M117.785287","article-title":"Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism","volume":"292","author":"VanderLinden","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108520_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature06924","article-title":"Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction","volume":"453","author":"Schreiner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.108520_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature06926","article-title":"Proteasome subunit Rpn13 is a novel ubiquitin receptor","volume":"453","author":"Husnjak","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.108520_bib7","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.str.2016.05.018","article-title":"Structures of rpn1 T1:Rad23 and hRpn13:hPLIC2 reveal distinct binding mechanisms between substrate receptors and shuttle factors of the proteasome","volume":"24","author":"Chen","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2025.108520_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.str.2020.02.007","article-title":"An extended conformation for K48 ubiquitin chains revealed by the hRpn2:rpn13:K48-diubiquitin structure","volume":"28","author":"Lu","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2025.108520_bib9","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ncb1460","article-title":"Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1","volume":"8","author":"Yao","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2025.108520_bib10","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1038\/sj.emboj.7601338","article-title":"A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes","volume":"25","author":"Hamazaki","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.108520_bib11","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1038\/sj.emboj.7601450","article-title":"hRpn13\/ADRM1\/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37","volume":"25","author":"Qiu","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.108520_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.18632\/genesandcancer.197","article-title":"HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1","volume":"10","author":"Santos-Barriopedro","year":"2019","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jbc.2025.108520_bib13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.molcel.2023.11.035","article-title":"hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-kappaB p50","volume":"84","author":"Osei-Amponsa","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2025.108520_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ccr.2013.11.001","article-title":"A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13\/ADRM1 as a therapy for cancer","volume":"24","author":"Anchoori","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2025.108520_bib15","doi-asserted-by":"crossref","first-page":"11917","DOI":"10.1021\/acsomega.8b01479","article-title":"Covalent rpn13-binding inhibitors for the treatment of ovarian cancer","volume":"3","author":"Anchoori","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.jbc.2025.108520_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227727","article-title":"Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties","volume":"15","author":"Anchoori","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.108520_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285221","article-title":"Development and anticancer properties of Up284, a spirocyclic candidate ADRM1\/RPN13 inhibitor","volume":"18","author":"Anchoori","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.108520_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305710","article-title":"Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13\/ADRM1 inhibitor for treatment of ovarian cancer","volume":"19","author":"Anchoori","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.108520_bib19","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1021\/jacs.5b02069","article-title":"A reversible and highly selective inhibitor of the proteasomal ubiquitin receptor rpn13 is toxic to multiple myeloma cells","volume":"137","author":"Trader","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.108520_bib20","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1038\/s41467-021-27570-4","article-title":"Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma","volume":"12","author":"Lu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.108520_bib21","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/s41467-024-46644-7","article-title":"A structure-based designed small molecule depletes hRpn13Pru and a select group of KEN box proteins","volume":"15","author":"Lu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.108520_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.37349\/etat.2020.00018","article-title":"Current strategies for the design of PROTAC linkers: a critical review","volume":"1","author":"Troup","year":"2020","journal-title":"Explor. Target Antitumor Ther."},{"key":"10.1016\/j.jbc.2025.108520_bib23","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jbc.2025.108520_bib24","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1038\/s41467-022-33430-6","article-title":"A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo","volume":"13","author":"Kofink","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.108520_bib25","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1021\/acs.jcim.0c00589","article-title":"PRosettaC: rosetta based modeling of PROTAC mediated ternary complexes","volume":"60","author":"Zaidman","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jbc.2025.108520_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbc.2025.108520_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0076-6879(01)39316-3","article-title":"Characterizing protein-protein complexes and oligomers by nuclear magnetic resonance spectroscopy","volume":"339","author":"Walters","year":"2001","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jbc.2025.108520_bib28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.str.2017.04.009","article-title":"Crystal structure of the Cul2-rbx1-EloBC-VHL ubiquitin ligase complex","volume":"25","author":"Cardote","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2025.108520_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2025.108520_bib30","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1080\/14796694.2024.2377530","article-title":"VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+\/HER2- advanced breast cancer","volume":"20","author":"Hamilton","year":"2024","journal-title":"Future Oncol."},{"key":"10.1016\/j.jbc.2025.108520_bib31","doi-asserted-by":"crossref","first-page":"16271","DOI":"10.1021\/acs.jmedchem.1c01576","article-title":"Integrative modeling of PROTAC-mediated ternary complexes","volume":"64","author":"Weng","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2025.108520_bib32","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.chembiol.2020.08.007","article-title":"Physical and functional analysis of the putative Rpn13 inhibitor RA190","volume":"27","author":"Dickson","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2025.108520_bib33","doi-asserted-by":"crossref","first-page":"e00122-20","DOI":"10.1128\/MCB.00122-20","article-title":"Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquitinated proteins and RA190 cytotoxicity","volume":"40","author":"Osei-Amponsa","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2025.108520_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/jmrb.1995.1109","article-title":"Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation","volume":"108","author":"Mori","year":"1995","journal-title":"J. Magn. Reson. B"},{"key":"10.1016\/j.jbc.2025.108520_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00197809","article-title":"NMRPipe: a multidimensional spectral processing system based on UNIX pipes","volume":"6","author":"Delaglio","year":"1995","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.jbc.2025.108520_bib36","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/bioinformatics\/btu830","article-title":"NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy","volume":"31","author":"Lee","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jbc.2025.108520_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00417486","article-title":"The program XEASY for computer-supported NMR spectral analysis of biological macromolecules","volume":"6","author":"Bartels","year":"1995","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.jbc.2025.108520_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jbc.2025.108520_bib39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-0134(19980901)32:4<399::AID-PROT1>3.0.CO;2-C","article-title":"Discrimination between native and intentionally misfolded conformations of proteins: ES\/IS, a new method for calculating conformational free energy that uses both dynamics simulations with an explicit solvent and an implicit solvent continuum model","volume":"32","author":"Vorobjev","year":"1998","journal-title":"Proteins"},{"key":"10.1016\/j.jbc.2025.108520_bib41","first-page":"326","article-title":"PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer Cell","volume":"31","author":"Torres-Ayuso","year":"2024","journal-title":"Chem. Biol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825003692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825003692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:15:44Z","timestamp":1761840944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825003692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0021925825003692"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108520","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of the PROTAC linker region of the proteasome substrate receptor hRpn13 rationalized by structural modeling with molecular dynamics","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"108520"}}